WealthTrust Axiom’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,854
Closed -$21K 262
2020
Q4
$21K Hold
3,854
0.01% 237
2020
Q3
$9K Hold
3,854
﹤0.01% 206
2020
Q2
$11K Hold
3,854
﹤0.01% 205
2020
Q1
$11K Buy
3,854
+2,674
+227% +$35.3K 0.01% 192
2019
Q4
$21K Hold
1,180
0.01% 229
2019
Q3
$23K Buy
1,180
+458
+63% +$9.03K 0.01% 235
2019
Q2
$13K Hold
722
﹤0.01% 238
2019
Q1
$13K Buy
722
+305
+73% +$5.94K ﹤0.01% 234
2018
Q4
$8K Hold
417
﹤0.01% 215
2018
Q3
$19K Buy
+417
New +$16.8K 0.01% 231

Other funds holding VANI

WealthTrust Axiom's VANI Position: Q1 2021 in Review

WealthTrust Axiom sold out of Vivani Medical (VANI) in Q1 2021, closing a stake of 3,854 shares — an estimated $21K sold.

WealthTrust Axiom first reported a position in VANI in Q3 2018 and held it in 10 quarters. The position peaked at $23K in Q3 2019. 30 funds tracked by Wall St. Rank hold VANI as of Q1 2021.

  • WealthTrust Axiom reported no remaining Vivani Medical position as of Q1 2021 after selling out during the quarter.
  • WealthTrust Axiom sold 3,854 Vivani Medical shares in Q1 2021, an estimated $21K.
  • WealthTrust Axiom first reported a position in Vivani Medical in Q3 2018 and held it in 10 quarters.
  • WealthTrust Axiom's Vivani Medical position peaked at $23K in Q3 2019.
  • 30 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2021.

Based on WealthTrust Axiom's 13F filing for Q1 2021, filed 14 Apr 2021.